Marshall & Sullivan Inc. WA Has $5.79 Million Stock Position in Danaher Co. (NYSE:DHR)

Marshall & Sullivan Inc. WA lifted its stake in Danaher Co. (NYSE:DHR) by 1.0% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 24,135 shares of the conglomerate’s stock after purchasing an additional 236 shares during the quarter. Danaher accounts for about 3.2% of Marshall & Sullivan Inc. WA’s investment portfolio, making the stock its 12th largest holding. Marshall & Sullivan Inc. WA’s holdings in Danaher were worth $5,792,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Freedom Wealth Alliance LLC purchased a new stake in Danaher in the 4th quarter worth about $27,000. Chelsea Counsel Co. purchased a new stake in Danaher in the 4th quarter worth about $27,000. GPS Wealth Strategies Group LLC purchased a new stake in Danaher in the 1st quarter worth about $25,000. Silicon Valley Capital Partners purchased a new stake in Danaher in the 1st quarter worth about $29,000. Finally, Stone House Investment Management LLC purchased a new stake in Danaher in the 1st quarter worth about $32,000. Institutional investors and hedge funds own 76.71% of the company’s stock.

Danaher Price Performance

Danaher stock opened at $253.82 on Tuesday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.70 and a current ratio of 2.08. Danaher Co. has a 52 week low of $221.22 and a 52 week high of $283.63. The firm has a market cap of $187.41 billion, a P/E ratio of 29.79, a P/E/G ratio of 2.75 and a beta of 0.80. The business’s fifty day moving average is $253.41 and its two-hundred day moving average is $245.09.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, July 25th. The conglomerate reported $2.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.01 by $0.04. Danaher had a return on equity of 15.03% and a net margin of 20.95%. The business had revenue of $7.16 billion for the quarter, compared to analyst estimates of $7.12 billion. During the same quarter in the prior year, the firm posted $2.76 earnings per share. The firm’s revenue for the quarter was down 7.7% compared to the same quarter last year. Equities research analysts forecast that Danaher Co. will post 8.84 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Thursday, October 12th will be paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.43%. The ex-dividend date of this dividend is Wednesday, October 11th. Danaher’s dividend payout ratio (DPR) is presently 12.68%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on DHR shares. Barclays increased their price objective on Danaher from $260.00 to $290.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 25th. Royal Bank of Canada raised their price target on Danaher from $260.00 to $292.00 in a research note on Wednesday, July 26th. StockNews.com assumed coverage on Danaher in a research note on Tuesday, September 12th. They set a “hold” rating for the company. Bank of America raised their price target on Danaher from $250.00 to $280.00 in a research note on Wednesday, July 26th. Finally, Raymond James raised their price target on Danaher from $270.00 to $290.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 26th. Five analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $289.79.

Insider Activity

In related news, Director Teri List sold 3,490 shares of the company’s stock in a transaction dated Wednesday, July 26th. The stock was sold at an average price of $263.30, for a total value of $918,917.00. Following the completion of the sale, the director now owns 17,494 shares in the company, valued at $4,606,170.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Danaher news, SVP Daniel Raskas sold 11,213 shares of the stock in a transaction dated Friday, July 28th. The stock was sold at an average price of $260.65, for a total value of $2,922,668.45. Following the completion of the sale, the senior vice president now directly owns 38,288 shares in the company, valued at $9,979,767.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Teri List sold 3,490 shares of the stock in a transaction dated Wednesday, July 26th. The stock was sold at an average price of $263.30, for a total value of $918,917.00. Following the transaction, the director now owns 17,494 shares of the company’s stock, valued at $4,606,170.20. The disclosure for this sale can be found here. Insiders have sold 47,922 shares of company stock valued at $12,552,233 over the last 90 days. 11.10% of the stock is owned by company insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.